Gefitinib plus chemotherapy vs gefitinib alone in untreated EGFR-mutant non–small cell lung cancer in patients with brain metastases: the GAP BRAIN open-label …
X Hou, M Li, G Wu, W Feng, J Su, H Jiang… - JAMA Network …, 2023 - jamanetwork.com
Importance Use of tyrosine kinase inhibitors (TKIs) is the standard therapy for epidermal
growth factor receptor (EGFR)–mutated non–small cell lung cancer (NSCLC) with brain …
growth factor receptor (EGFR)–mutated non–small cell lung cancer (NSCLC) with brain …
[HTML][HTML] Gefitinib Plus Chemotherapy vs Gefitinib Alone in Untreated EGFR-Mutant Non–Small Cell Lung Cancer in Patients With Brain Metastases: The GAP BRAIN …
X Hou, M Li, G Wu, W Feng, J Su, H Jiang… - JAMA Network …, 2023 - ncbi.nlm.nih.gov
Gefitinib Plus Chemotherapy vs Gefitinib Alone in Untreated EGFR-Mutant Non–Small Cell
Lung Cancer in Patients With Brain Metastases - PMC Back to Top Skip to main content NIH …
Lung Cancer in Patients With Brain Metastases - PMC Back to Top Skip to main content NIH …
Gefitinib Plus Chemotherapy vs Gefitinib Alone in Untreated EGFR-Mutant Non–Small Cell Lung Cancer in Patients With Brain Metastases: The GAP BRAIN Open …
X Hou, M Li, G Wu, W Feng, J Su, H Jiang… - JAMA Network …, 2023 - search.ebscohost.com
Abstract Key Points: Question: What are the efficacy and safety of gefitinib plus
chemotherapy in patients with untreated epidermal growth factor receptor (EGFR) mutated …
chemotherapy in patients with untreated epidermal growth factor receptor (EGFR) mutated …
Gefitinib Plus Chemotherapy vs Gefitinib Alone in Untreated EGFR-Mutant Non-Small Cell Lung Cancer in Patients With Brain Metastases: The GAP BRAIN Open …
X Hou, M Li, G Wu, W Feng, J Su… - JAMA network …, 2023 - pubmed.ncbi.nlm.nih.gov
Importance Use of tyrosine kinase inhibitors (TKIs) is the standard therapy for epidermal
growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) with brain …
growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) with brain …
Gefitinib Plus Chemotherapy vs Gefitinib Alone in Untreated EGFR-Mutant Non-Small Cell Lung Cancer in Patients With Brain Metastases: The GAP BRAIN Open …
X Hou, M Li, G Wu, W Feng, J Su, H Jiang… - JAMA Network …, 2023 - europepmc.org
Gefitinib Plus Chemotherapy vs Gefitinib Alone in Untreated EGFR-Mutant Non-Small Cell
Lung Cancer in Patients With Brain Metastases: The GAP BRAIN Open-Label, Randomized …
Lung Cancer in Patients With Brain Metastases: The GAP BRAIN Open-Label, Randomized …
Gefitinib Plus Chemotherapy vs Gefitinib Alone in Untreated EGFR-Mutant Non-Small Cell Lung Cancer in Patients With Brain Metastases: The GAP BRAIN Open …
X Hou, M Li, G Wu, W Feng, J Su, H Jiang… - JAMA Network …, 2023 - europepmc.org
Gefitinib Plus Chemotherapy vs Gefitinib Alone in Untreated EGFR-Mutant Non-Small Cell
Lung Cancer in Patients With Brain Metastases: The GAP BRAIN Open-Label, Randomized …
Lung Cancer in Patients With Brain Metastases: The GAP BRAIN Open-Label, Randomized …